ArticleJournal of thoracic disease2025
Efficacy and safety of self-expandable metallic stent on benign tracheobronchial stenosis: a systematic review and meta-analysis.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Relationship between airway stents and airway microorganisms: a literature review.Journal of thoracic disease · 2026Review
- Traumatic Complete Occlusion of the Left Main Bronchus Managed by Temporary Placement of a Covered Self-Expandable Metallic Stent: A Case Report.The American journal of case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The safety and efficacy of self-expandable metallic stent (SEMS) in the management of benign tracheobronchial stenosis (TBS) remain elusive. This study aimed to provide comprehensive insights into the efficacy and safety of SEMS in treating benign TBS. Methods: We conducted a meta-analysis to elucidate the safety and efficacy of the SEMS in benign TBS. Data on related trials were obtained by doing a literature search in PubMed, Cochrane Library, Web of Science and Embase. Random-effect models were used to calculate the efficacy and incidence of complication of SEMS treatment. Results: Data of 797 participants who received 1,236 SEMS during 26.0±13.5 months of follow-up period were included and analyzed. The main causes of benign TBS included tracheotomy (32.8%), anastomotic stenosis after transplantation or lobectomy (31.3%), tracheal intubation (18.1%), and other benign diseases (17.8%). The total effective rate of SEMS in the treatment of benign TBS was 56.4%, but varied from different etiologies: iatrogenic injury 41.5%, tuberculous infection 83.3%, autoimmune disease 46.2%, and external compression 75%, respectively. The average time of stents placement was 6.59±4.96 months, while the success rate of stent removal was 98.7%. The overall incidence of complications after stent implantation was 45%, including airway restenosis 16.7%, granulation tissue hyperplasia 27.9%, mucus retention 19%, stent migration 20.1%, and stent rupture 25.7%. Airway stent-related mortality was rarely occurred. Conclusions: SEMS could serve as a relatively effective and safe treatment for benign TBS with intensive observation and follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.